Neoadjuvant immune checkpoint blockade triggers persistent and systemic T <sub>reg</sub> activation which blunts therapeutic efficacy against metastatic spread of breast tumors-Reference-Cited by-同舟云学术

Neoadjuvant immune checkpoint blockade triggers persistent and systemic T _reg activation which blunts therapeutic efficacy against metastatic spread of breast tumors

Published:2023-04-13 Issue:1 Volume:12 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Blomberg Olga S.¹²³,Kos Kevin¹²³,Spagnuolo Lorenzo¹²,Isaeva Olga I.¹,Garner Hannah¹²,Wellenstein Max D.¹²³,Bakker Noor¹²³,Duits Danique E.M.¹²³,Kersten Kelly¹,Klarenbeek Sjoerd⁴,Hau Cheei-Sing¹²,Kaldenbach Daphne¹²,Raeven Elisabeth A.M.¹²,Vrijland Kim¹²,Kok Marleen¹⁵,de Visser Karin E.¹²³^ORCID

Affiliation:

1. Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands

2. Oncode Institute, Utrecht, The Netherlands

3. Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands

4. Experimental Animal Pathology Facility, Netherlands Cancer Institute, Amsterdam, Netherlands

5. Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands

Funder

Oncode Institute

KWF/Oncode consortium

NWO Oncology Graduate School Amsterdam Diamond Program

Swiss National Science Foundation

BMS-International Immuno-Oncology Network